Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$129.72 - $159.85 $3,372 - $4,156
26 New
26 $4,000
Q1 2021

May 14, 2021

SELL
$150.19 - $173.5 $18,022 - $20,820
-120 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$95.68 - $121.88 $150,696 - $191,961
-1,575 Reduced 92.92%
120 $13,000
Q1 2020

May 06, 2020

SELL
$87.74 - $152.74 $28,515 - $49,640
-325 Reduced 16.09%
1,695 $169,000
Q3 2019

Nov 13, 2019

SELL
$125.18 - $143.24 $87,626 - $100,268
-700 Reduced 25.74%
2,020 $258,000
Q2 2019

Aug 16, 2019

SELL
$125.55 - $144.48 $125,550 - $144,480
-1,000 Reduced 26.88%
2,720 $387,000
Q4 2018

Jan 30, 2019

BUY
$115.94 - $166.74 $115,940 - $166,740
1,000 Added 36.76%
3,720 $461,000
Q1 2018

Apr 20, 2018

BUY
$135.59 - $157.16 $16,270 - $18,859
120 Added 4.62%
2,720 $410,000
Q3 2017

Oct 25, 2017

BUY
$142.62 - $155.6 $370,812 - $404,560
2,600
2,600 $380,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.